Explore more publications!
Copenhagen News Network
Got News to Share?

Press Releases

AI in Wound Care Market Projected to Achieve a 35.03% CAGR, Expanding from USD 0.64 Billion to USD 12.9 Billion by 2034
Feb. 4, 2026

AI in Wound Care Market Projected to Achieve a 35.03% CAGR, Expanding from USD 0.64 Billion to USD 12.9 Billion by 2034

Indeterminate GlobeNewswire, Inc.
Diabetic Neuropathy Treatment Market Set to Grow from USD 4.71 Billion in 2024 to USD 9.93 Billion by 2034
Feb. 4, 2026

Diabetic Neuropathy Treatment Market Set to Grow from USD 4.71 Billion in 2024 to USD 9.93 Billion by 2034

Indeterminate GlobeNewswire, Inc.
Global Freight Forwarding Market Size to Reach USD 536.51 Billion by 2034 | Growth Forecast 2026–2034
Feb. 4, 2026

Global Freight Forwarding Market Size to Reach USD 536.51 Billion by 2034 | Growth Forecast 2026–2034

Neutral EIN Presswire
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jan. 16, 2026

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Indeterminate GlobeNewswire, Inc.
Pharmaceuticals Market to Register a Robust CAGR of 8.19% During the 2026–2034 Forecast Period
Feb. 4, 2026

Pharmaceuticals Market to Register a Robust CAGR of 8.19% During the 2026–2034 Forecast Period

Neutral EIN Presswire
Deutsche Telekom and T-Mobile US executives join TM Forum Board
Feb. 4, 2026

Deutsche Telekom and T-Mobile US executives join TM Forum Board

Neutral EIN Presswire
LiqTech Strengthens Position in Large-Scale Produced-Water Reuse with QureFlow™ Max
Feb. 4, 2026

LiqTech Strengthens Position in Large-Scale Produced-Water Reuse with QureFlow™ Max

Neutral EIN Presswire
ComplyCube Expands Global Reach with eID and SSN Verification
Feb. 4, 2026

ComplyCube Expands Global Reach with eID and SSN Verification

Neutral EIN Presswire
trivago N.V. reports solid Q4 2025 results, achieving 27% YoY revenue growth
Feb. 3, 2026

trivago N.V. reports solid Q4 2025 results, achieving 27% YoY revenue growth

Indeterminate GlobeNewswire, Inc.
Danish Energy Group provides the key to a smarter and greener future
Jan. 15, 2026

Danish Energy Group provides the key to a smarter and greener future

Neutral EIN Presswire
Scento Surpasses 85,000 Members as Europe's Largest Authenticated Perfume Platform
Feb. 3, 2026

Scento Surpasses 85,000 Members as Europe's Largest Authenticated Perfume Platform

Neutral EIN Presswire
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
Feb. 3, 2026

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

Indeterminate GlobeNewswire, Inc.
Starch Derivatives Market Size to Worth USD 148.33 Billion by 2035 | Towards FnB
Feb. 3, 2026

Starch Derivatives Market Size to Worth USD 148.33 Billion by 2035 | Towards FnB

Indeterminate GlobeNewswire, Inc.
Medical Equipment Maintenance Market Size and Growth Analysis (2025-2034)
Feb. 3, 2026

Medical Equipment Maintenance Market Size and Growth Analysis (2025-2034)

Indeterminate GlobeNewswire, Inc.
Pinewood.AI Debuts New AI Agent for Automated Dealership Tasks
Feb. 3, 2026

Pinewood.AI Debuts New AI Agent for Automated Dealership Tasks

Indeterminate GlobeNewswire, Inc.
Orthodontics Market Set to Surge from USD 7.65 Billion in 2024 to USD 38.21 Billion by 2034 at 17.45% CAGR
Feb. 3, 2026

Orthodontics Market Set to Surge from USD 7.65 Billion in 2024 to USD 38.21 Billion by 2034 at 17.45% CAGR

Indeterminate GlobeNewswire, Inc.
Meeting House Collaborative Awarded $100,000 USDA Specialty Crop Grant to Help Expand Maine Organic Herb Production
Feb. 3, 2026

Meeting House Collaborative Awarded $100,000 USDA Specialty Crop Grant to Help Expand Maine Organic Herb Production

Neutral EIN Presswire
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Jan. 23, 2026

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity

Indeterminate GlobeNewswire, Inc.
Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment
Feb. 3, 2026

Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment

Indeterminate GlobeNewswire, Inc.
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
Feb. 3, 2026

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions